Tempest Therapeutics, Inc. (TPST): Capital Expenditures
$0
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | -100.0% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $435.0K | +155.9% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $170.0K | -69.8% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $562.0K | +316.3% | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | $135.0K | +170.0% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $50.0K | n/c | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $397.0K | n/m | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $36.0K | +800.0% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $4.0K | -99.8% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $2.59M | -50.5% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $5.23M | +86.5% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $2.80M | +290.0% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $719.0K | -15.3% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $849.0K | n/a | 2015-03-16, From 2012-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | $0 | -100.0% |
| Lipocine Inc. (LPCN) | 2024-12-31 | $90.1K | +584.2% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | $13.7K | n/a |
| Mustang Bio, Inc. (MBIO) | 2024-12-31 | $0 | -100.0% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $28.0K | n/a |
| Aprea Therapeutics, Inc. (APRE) | 2024-12-31 | $15.5K | -83.4% |
| Clene Inc. (CLNN) | 2025-12-31 | $39.0K | +160.0% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.0K | -97.3% |
| Lite Strategy, Inc. (LITS) | 2025-06-30 | $0 | -100.0% |
Compare TPST, LPCN, ADTX, MBIO side by side · Screen every company in Pharmaceutical Preparations ↗